Literature DB >> 6945304

On the mechanism of aryl sulfotransferase.

M W Duffel, W B Jakoby.   

Abstract

Aryl sulfotransferase IV (EC 2.8.2.1), purified to homogeneity from male rat liver, catalyzes the sulfation of a variety of substituted phenols, including catecholamines, tyrosine esters, and peptides containing NH2-terminal tyrosine residues. An investigation of the mechanism of the enzyme was carried out using 2-chloro-4-nitrophenol as a model substrate. Kinetic, inhibition, and binding studies with aryl sulfotransferase IV are all consistent with a random rapid equilibrium Bi Bi kinetic mechanism with two dead end product inhibitor complexes. Studies of the chemical mechanisms of the enzyme-catalyzed reaction demonstrate that electron-withdrawing substituents decrease the maximal velocity of phenol sulfation. The maximal velocity of the reaction correlates with Hammett sigma p- constants (rho = -0.25). Evidence is presented for the mechanism by which adenosine 3',5'-bisphosphate and aryl sulfotransferase catalyze the transfer of sulfate from 2-chloro-4-nitrophenyl sulfate to other phenols.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6945304

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  Mechanistic studies of beta-arylsulfotransferase IV.

Authors:  Eli Chapman; Marian C Bryan; Chi-Huey Wong
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-23       Impact factor: 11.205

2.  Oxidative modification of rat sulfotransferase 1A1 activity in hepatic tissue slices correlates with effects on the purified enzyme.

Authors:  Jagadeesha K Dammanahalli; Michael W Duffel
Journal:  Drug Metab Dispos       Date:  2011-10-31       Impact factor: 3.922

Review 3.  Structure, dynamics and selectivity in the sulfotransferase family.

Authors:  Thomas S Leyh; Ian Cook; Ting Wang
Journal:  Drug Metab Rev       Date:  2013-09-11       Impact factor: 4.518

4.  Substrate inhibition in human hydroxysteroid sulfotransferase SULT2A1: studies on the formation of catalytically non-productive enzyme complexes.

Authors:  Hayrettin Ozan Gulcan; Michael W Duffel
Journal:  Arch Biochem Biophys       Date:  2010-12-25       Impact factor: 4.013

Review 5.  Design and Interpretation of Human Sulfotransferase 1A1 Assays.

Authors:  Ting Wang; Ian Cook; Thomas S Leyh
Journal:  Drug Metab Dispos       Date:  2015-12-09       Impact factor: 3.922

6.  Removal of substrate inhibition and increase in maximal velocity in the short chain dehydrogenase/reductase salutaridine reductase involved in morphine biosynthesis.

Authors:  Jörg Ziegler; Wolfgang Brandt; René Geissler; Peter J Facchini
Journal:  J Biol Chem       Date:  2009-07-30       Impact factor: 5.157

7.  Structural rearrangement of SULT2A1: effects on dehydroepiandrosterone and raloxifene sulfation.

Authors:  Ian T Cook; Thomas S Leyh; Susan A Kadlubar; Charles N Falany
Journal:  Horm Mol Biol Clin Investig       Date:  2010

8.  Structural characterization of human aryl sulphotransferases.

Authors:  L A Brix; R G Duggleby; A Gaedigk; M E McManus
Journal:  Biochem J       Date:  1999-01-15       Impact factor: 3.857

9.  Isotope exchange at equilibrium indicates a steady state ordered kinetic mechanism for human sulfotransferase.

Authors:  Eduard Tyapochkin; Paul F Cook; Guangping Chen
Journal:  Biochemistry       Date:  2008-10-18       Impact factor: 3.162

10.  para-Nitrophenyl sulfate activation of human sulfotransferase 1A1 is consistent with intercepting the E[middle dot]PAP complex and reformation of E[middle dot]PAPS.

Authors:  Eduard Tyapochkin; Paul F Cook; Guangping Chen
Journal:  J Biol Chem       Date:  2009-08-25       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.